SCHEMBL30407627

SCHEMBL30407627

O=C(CCOCCOCCOCCOCCNC(=O)[C@H](NC(=O)OCc1ccccc1)[C@@H](NC(=O)OCc1ccccc1)C(=O)NCCCC(=O)Oc1c(F)c(F)c(F)c(F)c1F)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CAPN1 P07384 1/20 0.44
▸ CAPN2 P17655 1/20 0.44
▸ CTSL P07711 2/20 0.43
▸ CTSS P25774 2/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ CTSB P07858 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CTSK P43235 2/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29467632 0.97 CAPN1 (0.45) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL29467710 0.93 SMN1; SMN2 (0.46) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL30407736 0.87 HTT (0.57) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL30407162 0.86 SMN1; SMN2 (0.47) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL29467716 0.84 HTT (0.53) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL27438957 0.83 LMNA (0.47) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL27438917 0.83 LMNA (0.47) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL29467718 0.83 CAPN1 (0.47) SMN1; SMN2LMNACAPN1CAPN2CTSL
SCHEMBL20577215 0.81 LMNA (0.47) SMN1; SMN2LMNAMEN1KMT2AALDH1A1
SCHEMBL29467703 0.80 HTT (0.57) SMN1; SMN2LMNACAPN1CAPN2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426741-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE Hangzhou DAC Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
EP-4426729-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE Hangzhou Dac Biotech Co., Ltd. (CN) 2024-09-11 — — EP disclosed
WO-2023078021-A1 BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
WO-2023078273-A1 SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-05-11 — — WO disclosed
Send feedback